Enteral nutritional support in patients undergoing chemoradiotherapy for esophageal carcinoma

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Chen W, Zheng R, Baade PD et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 66(2), 115–132 (2016).
  MedlineGoogle Scholar
• 2. Ma L, Luo GY, Ren YF et al. Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae. Chin. J. Cancer 36(1), 8 (2017).
  MedlineGoogle Scholar
• 3. Mak M, Bell K, Ng W, Lee M. Nutritional status, management and clinical outcomes in patients with esophageal and gastro-oesophageal cancers: a descriptive study. Nutr. Diet. 74(3), 229–235 (2017).
  MedlineGoogle Scholar
• 4. Hebuterne X, Lemarie E, Michallet M, de Montreuil CB, Schneider SM, Goldwasser F. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN J. Parenter. Enteral Nutr. 38(2), 196–204 (2014).
  MedlineGoogle Scholar
• 5. Arends J, Bodoky G, Bozzetti F et al. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin. Nutr. 25(2), 245–259 (2006). • Specifically elucidated enteral nutrition in patients with head and neck or esophageal cancer and mentioned the indications and goals of enteral nutrition.
  Medline CASGoogle Scholar
• 6. Lyu J, Li T, Xie C et al. Enteral nutrition in esophageal cancer patients treated with radiotherapy: a Chinese expert consensus 2018. Future Oncol. 15(5), 517–531 (2019). •• First Chinese expert consensus of enteral nutrition in esophageal cancer patients treated with radiotherapy, which has important guiding significance.
  CASGoogle Scholar
• 7. Isenring E, Bauer J, Capra S. The scored Patient-Generated Subjective Global Assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. Eur. J. Clin. Nutr. 57(2), 305–309 (2003).
  Medline CASGoogle Scholar
• 8. Jager-Wittenaar H, Ottery FD. Assessing nutritional status in cancer: role of the Patient-Generated Subjective Global Assessment. Curr. Opin. Clin. Nutr. Metab. Care 20(5), 322–329 (2017).
  MedlineGoogle Scholar
• 9. Vigano AL, di Tomasso J, Kilgour RD et al. The abridged Patient-Generated Subjective Global Assessment is a useful tool for early detection and characterization of cancer cachexia. J. Acad. Nutr. Diet 114(7), 1088–1098 (2014).
  MedlineGoogle Scholar
• 10. Kim JY, Wie GA, Cho YA et al. Development and validation of a nutrition screening tool for hospitalized cancer patients. Clin. Nutr. 30(6), 724–729 (2011).
  MedlineGoogle Scholar
• 11. Persson C, Sjoden PO, Glimelius B. The Swedish version of the Patient-Generated Subjective Global Assessment of nutritional status: gastrointestinal vs urological cancers. Clin. Nutr. 18(2), 71–77 (1999).
  Medline CASGoogle Scholar
• 12. Read JA, Crockett N, Volker DH et al. Nutritional assessment in cancer: comparing the Mini Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PG-SGA). Nutr. Cancer 53(1), 51–56 (2005).
  MedlineGoogle Scholar
• 13. Bauer JM, Vogl T, Wicklein S, Trögner J, Mühlberg W, Sieber CC. Comparison of the Mini Nutritional Assessment, Subjective Global Assessment, and Nutritional Risk Screening (NRS 2002) for nutritional screening and assessment in geriatric hospital patients. Z. Gerontol. Geriatr. 38(5), 322–327 (2005).
  Medline CASGoogle Scholar
• 14. Ye XJ, Ji YB, Ma BW et al. Comparison of three common nutritional screening tools with the new European Society for Clinical Nutrition and Metabolism (ESPEN) criteria for malnutrition among patients with geriatric gastrointestinal cancer: a prospective study in China. BMJ Open 8(4), e019750 (2018).
  MedlineGoogle Scholar
• 15. Almeida AI, Correia M, Camilo M, Ravasco P. Nutritional risk screening in surgery: valid, feasible, easy! Clin. Nutr. 31(2), 206–211 (2012).
  MedlineGoogle Scholar
• 16. Ryu SW, Kim IH. Comparison of different nutritional assessments in detecting malnutrition among gastric cancer patients. World J. Gastroenterol. 16(26), 3310–3317 (2010).
  MedlineGoogle Scholar
• 17. Orell-Kotikangas H, Osterlund P, Saarilahti K, Ravasco P, Schwab U, Makitie AA. NRS-2002 for pre-treatment nutritional risk screening and nutritional status assessment in head and neck cancer patients. Support. Care Cancer 23(6), 1495–1502 (2015).
  MedlineGoogle Scholar
• 18. Thoresen L, Fjeldstad I, Krogstad K, Kaasa S, Falkmer UG. Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med. 16(1), 33–42 (2002).
  MedlineGoogle Scholar
• 19. Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF. Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur. J. Clin. Nutr. 59(1), 35–40 (2005).
  Medline CASGoogle Scholar
• 20. Kwang AY, Kandiah M. Objective and subjective nutritional assessment of patients with cancer in palliative care. Am. J. Hosp. Palliat. Care 27(2), 117–126 (2010).
  MedlineGoogle Scholar
• 21. Lloyd S, Chang BW. Current strategies in chemoradiation for esophageal cancer. J. Gastrointest. Oncol. 5(3), 156–165 (2014).
  MedlineGoogle Scholar
• 22. Rietveld SCM, Witvliet-van Nierop JE, Ottens-Oussoren K, van der Peet DL, de van der Schueren MAE. The prediction of deterioration of nutritional status during chemoradiation therapy in patients with esophageal cancer. Nutr. Cancer. 70(2), 229–235 (2018).
  MedlineGoogle Scholar
• 23. Qiu Y, You J, Wang K et al. Effect of whole-course nutrition management on patients with esophageal cancer undergoing concurrent chemoradiotherapy: a randomized control trial. Nutrition 69, 110558 (2020). • Different from previous studies, this compared the whole-course nutrition management of patients with general nutrition treatment of esophageal cancer undergoing concurrent chemoradiotherapy.
  Medline CASGoogle Scholar
• 24. Correia MI, Waitzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin. Nutr. 22(3), 235–239 (2003).
  MedlineGoogle Scholar
• 25. Arends J, Baracos V, Bertz H et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin. Nutr. 36(5), 1187–1196 (2017).
  Medline CASGoogle Scholar
• 26. Mayanagi S, Tsubosa Y, Omae K et al. Negative impact of skeletal muscle wasting after neoadjuvant chemotherapy followed by surgery on survival for patients with thoracic esophageal cancer. Ann. Surg. Oncol. 24(12), 3741–3747 (2017).
  MedlineGoogle Scholar
• 27. Reisinger KW, Bosmans JW, Uittenbogaart M et al. Loss of skeletal muscle mass during neoadjuvant chemoradiotherapy predicts postoperative mortality in esophageal cancer surgery. Ann. Surg. Oncol. 22(13), 4445–4452 (2015).
  MedlineGoogle Scholar
• 28. Miller KR, Bozeman MC. Nutrition therapy issues in esophageal cancer. Curr. Gastroenterol. Rep. 14(4), 356–366 (2012).
  MedlineGoogle Scholar
• 29. Evans JA, Early DS, Chandraskhara V et al. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest. Endosc. 77(3), 328–334 (2013).
  MedlineGoogle Scholar
• 30. Spaander MC, Baron TH, Siersema PD et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy 48(10), 939–948 (2016).
  MedlineGoogle Scholar
• 31. Battersby NJ, Bonney GK, Subar D, Talbot L, Decadt B, Lynch N. Outcomes following oesophageal stent insertion for palliation of malignant strictures: a large single centre series. J. Surg. Oncol. 105(1), 60–65 (2012).
  MedlineGoogle Scholar
• 32. Mao-de-Ferro S, Serrano M, Ferreira S et al. Stents in patients with esophageal cancer before chemoradiotherapy: high risk of complications and no impact on the nutritional status. Eur. J. Clin. Nutr. 70(3), 409–410 (2016).
  Medline CASGoogle Scholar
• 33. Lin CH, Liu NJ, Lee CS et al. Nasogastric feeding tube placement in patients with esophageal cancer: application of ultrathin transnasal endoscopy. Gastrointest. Endosc. 64(1), 104–107 (2006).
  MedlineGoogle Scholar
• 34. Grilo A, Santos CA, Fonseca J. Percutaneous endoscopic gastrostomy for nutritional palliation of upper esophageal cancer unsuitable for esophageal stenting. Arq. Gastroenterol. 49(3), 227–231 (2012).
  MedlineGoogle Scholar
• 35. Blomberg J, Lagergren J, Martin L, Mattsson F, Lagergren P. Complications after percutaneous endoscopic gastrostomy in a prospective study. Scand. J. Gastroenterol. 47(6), 737–742 (2012).
  MedlineGoogle Scholar
• 36. Keung EZ, Liu X, Nuzhad A, Rabinowits G, Patel V. In-hospital and long-term outcomes after percutaneous endoscopic gastrostomy in patients with malignancy. J. Am. Coll. Surg. 215(6), 777–786 (2012).
  MedlineGoogle Scholar
• 37. Kakuta T, Kosugi SI, Ichikawa H et al. Palliative interventions for patients with incurable locally advanced or metastatic thoracic esophageal carcinoma. Esophagus 16(3), 278–284 (2019). • Discusses palliative intervention for patients with advanced esophageal cancer, suggesting we should choose appropriate nutritional interventions based on patient situation.
  MedlineGoogle Scholar
• 38. Yu FJ, Shih HY, Wu CY et al. Enteral nutrition and quality of life in patients undergoing chemoradiotherapy for esophageal carcinoma: a comparison of nasogastric tube, esophageal stent, and ostomy tube feeding. Gastrointest. Endosc. 88(1), 21–31 (2018). • Compared the effects of three enteral nutrition interventions and their advantages and disadvantages.
  MedlineGoogle Scholar
• 39. Sofue K, Takeuchi Y, Tsurusaki M et al. Value of percutaneous radiologic gastrostomy for patients with advanced esophageal cancer. Ann. Surg. Oncol. 23(11), 3623–3631 (2016).
  MedlineGoogle Scholar
• 40. Jiang XY, Bertrand AS, Li G et al. CT-guided percutaneous gastrostomy without preliminary placement of a nasogastric tube. J. Vasc. Interv. Radiol. 30(6), 915–917 (2019).
  MedlineGoogle Scholar
• 41. Min YW, Jang EY, Jung JH et al. Comparison between gastrostomy feeding and self-expandable metal stent insertion for patients with esophageal cancer and dysphagia. PLoS One 12(6), e0179522 (2017).
  MedlineGoogle Scholar
• 42. Prado CM, Baracos VE, McCargar LJ et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin. Cancer Res. 13(11), 3264–3268 (2007).
  Medline CASGoogle Scholar
• 43. Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr. J. 9, 69 (2010).
  MedlineGoogle Scholar
• 44. Cederholm T, Bosaeus I, Barazzoni R et al. Diagnostic criteria for malnutrition – an ESPEN consensus statement. Clin. Nutr. 34(3), 335–340 (2015).
  Medline CASGoogle Scholar
• 45. Cox S, Powell C, Carter B, Hurt C, Mukherjee S, Crosby TD. Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1. Br. J. Cancer 115(2), 172–177 (2016).
  Medline CASGoogle Scholar
• 46. Yokota T, Ando N, Igaki H et al. Prognostic factors in patients receiving neoadjuvant 5-fluorouracil plus cisplatin for advanced esophageal cancer (JCOG9907). Oncology 89(3), 143–151 (2015).
  Medline CASGoogle Scholar
• 47. Gibbs J, Cull W, Henderson W et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch. Surg. 134(1), 36–42 (1999).
  Medline CASGoogle Scholar
• 48. Jiang N, Zhao JZ, Chen XC et al. Clinical determinants of weight loss in patients with esophageal carcinoma during radiotherapy: a prospective longitudinal view. Asian Pac. J. Cancer Prev. 15(5), 1943–1948 (2014).
  MedlineGoogle Scholar
• 49. Li B, Lu Z, Wang S et al. Pretreatment elevated prognostic nutritional index predicts a favorable prognosis in patients with prostate cancer. BMC Cancer 20(1), 361 (2020).
  Medline CASGoogle Scholar
• 50. Xia LJ, Li W, Zhai JC et al. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1–2 rectal cancer. BMC Cancer 20(1), 208 (2020).
  Medline CASGoogle Scholar
• 51. Akgül Ö, Çetinkaya E, Yalaza M et al. Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection. World J. Gastrointest. Oncol. 9(7), 300–307 (2017).
  MedlineGoogle Scholar
• 52. Gaurav K, Goel RK, Shukla M, Pandey M. Glutamine: a novel approach to chemotherapy-induced toxicity. Indian J. Med. Paediatr. Oncol. 33(1), 13–20 (2012).
  MedlineGoogle Scholar
• 53. Sun ZW, Jia J, Yang Y et al. Enteral nutrition support reduces toxicity of chemotherapy in patients with advanced or metastatic esophageal cancer. Beijing Da Xue Xue Bao Yi Xue Ban. 52(2), 261–268 (2020).
  Medline CASGoogle Scholar
• 54. Cong MH, Li SL, Cheng GW et al. An interdisciplinary nutrition support team improves clinical and hospitalized outcomes of esophageal cancer patients with concurrent chemoradiotherapy. Chin. Med. J. 128(22), 3003–3007 (2015).
  Medline CASGoogle Scholar
• 55. Buntzel J, Krauss T, Buntzel H et al. Nutritional parameters for patients with head and neck cancer. Anticancer Res. 32(5), 2119–2123 (2012).
  MedlineGoogle Scholar